THE METROLOGICAL ASPECTS OF DIOSMIN QUANTITATION IN PHARMACEUTICAL DOSAGE FORMS

Authors:
  • AVA.V. Voronin
    A.V. Voronin
  • AKA.V. Karpov
    A.V. Karpov

Abstract
Pharmaceutical dosage forms with diosmin in Russian Federation are allowed for medical using. Simple and informative methods of diosmin quantitation for drug quality control are needed. Background. The metrological parameters determination of diosmin quantitation in pharmaceutical dosage forms by UV-spectrophotometry. Methods. The study subject was Venarus®, Detralex® (tablets, suspension), Phlebopha®. Diosmin was quantified by UV-spectrophotometry. The reference-specific absorbance values of diosmin at wavelengths of 268 nm and 370 nm by the parameters of calibration was determined. Statistical data processing was carried out by methods of variation statistics, correlation, one-way analysis of variance using computer programs ChemMetr 1.0, ChemMetr Evaluation 1.0, Statistica 6.0 (Statsoft Inc., USA). Result. The range of diosmin quantitation by UVspectrophotometry was for wavelengths: 268 nm – 0,0001-0,001%, 370 nm – 0,0002-0,002%. The referencespecific absorbance values for diosmin at wavelengths of 268 nm and 370 nm in a sodium hydroxide solution 0,02M were 463,0±24,6 and 259,0±9,9 respectively. The means errors of diosmin concentrations in pharmaceutical dosage forms were for wavelength 268 nm – 8-12% and for 370 nm – 6-8%. On example Detralex® tablets analysis a prognostic calculation of the sample preparation error (extraction) for diosmin was performed. The sample preparation error was 8%. Conclusion. The values components of error for referencespecific absorbance value and sample preparation error for diosmin quantitation was determined (on example analysis Detralex® tablets). Calculation algorithms can be used to theoretically error estimate of sample preparation for other multicomponent samples in drug quality control.